Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-045326

Chief Financial Officer acquired 245,450 shares (option exercise)

  • Chief Financial Officer acquired 114,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Buck Paul · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-08-12 Conversion : show line 1 in the form +114,000 $0.25 $28,500 236,083 D
2013-08-12 Exercise or conversion : show line 2 in the form +245,450 $0.25 $61,363 481,533 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2013-08-09 Purchase : show line 3 in the form Convertible Promissory Note +0 D
2013-08-12 Conversion : show line 4 in the form Convertible Promissory Note +0 D
2013-08-12 Exercise or conversion : show line 5 in the form Convertible Promissory Note +0 0 D
Loading xslF345X03/v352923_4.xml…